INVESTING IN LIFE, NON-LIFE AND ALTERNATIVE CREDIT INSURANCE LINKED STRATEGIES

Leadenhall Capital Partners is an FCA, SEC and BMA registered investment management group, focused on investing in Life, Non-Life and Alternative Credit insurance linked investments portfolios for institutional investors. Established in 2008, we have a highly experienced team with Leadenhall partners having 250+ years insurance & capital markets experience earned at major financial institutions, reinsurance firms, broking houses and the Lloyd’s of London insurance market.

Through Leadenhall Life strategies, investors can access returns from the life insurance linked strategies which include mortality, morbidity & lapse risks. Through its Non-Life investment strategies (private placements and cat bonds), Leadenhall offers investors access to pure (re)insurance risk, which has exposure to property losses from extreme natural catastrophes (e.g., major hurricanes and earthquakes) and other Non-Life insurable risks (e.g., marine risk, other specialty products). Through Leadenhall Alternative Private Credit strategies, investors can access returns from the private credit insurance market by providing financing to entities in the life, health, and non-life sectors where we combine credit experience and familiarity with the insurance risk landscape.

Leadenhall was established in 2008 as a joint venture between a Global Specialty (re)Insurer, Amlin, and a highly experienced management team. Amlin was acquired in 2016 by the MS&AD Group (a Japanese insurance company listed as a component of the Nikkei 225) and rebranded MS Amlin. MS Amlin’s participation in Leadenhall was transferred to Mitsui Sumitomo Insurance (a subsidiary of MS&AD). This allows Leadenhall to cooperate more effectively with various entities of the MSI Group, including maintaining our relationship with MS Amlin.